Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00303368 · ClinicalTrials.gov registry record
Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia
A clinical trial, sponsored by Shriners Hospitals for Children.
- Completed
- Registry status
- 395
- Enrollment target
NCT00303368: Completed study, sponsored by Shriners Hospitals for Children.
NCT00303368 is a clinical trial that has completed, run by Shriners Hospitals for Children. The registered enrollment target is 395 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00303368 has completed, sponsored by Shriners Hospitals for Children.
- COMPLETED
- Registry status
- 395 participants
- Enrollment target
Study Summary
The study is a multicenter four-year outcome study of the natural history of tibial dysplasia in patients with NF1 and selected patients without NF1. We will obtain information on the natural history, burden, functional and health status, health-related quality of life, and surgical interventions/outcomes of tibial dysplasia. The project will also establish a Core Facility (NOCF) for tissue samples for future studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 395 participants |
| Start Date | 2004-03 |
| Est. Completion | 2016-01 |
What the finished NCT00303368 record still lists
NCT00303368 is an observational study that tracks outcomes without assigning an intervention. The registered 395 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00303368 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00303368 about?
NCT00303368 is a clinical study titled "Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia". The study is a multicenter four-year outcome study of the natural history of tibial dysplasia in patients with NF1 and selected patients without NF1. We will obtain information on the natural history, burden, functional and health status, health-related quality of life, and surgical interventions/ou...
What is the current status of trial NCT00303368?
This trial is currently completed. The enrollment target is 395 participants. The study started on 2004-03. Estimated completion is 2016-01.
Who is sponsoring clinical trial NCT00303368?
This trial is sponsored by Shriners Hospitals for Children, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07207369 · 395 participants · Phase 3
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
- NCT05633615 · 396 participants · Phase 2
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- NCT06227910 · 396 participants · Phase 3
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- NCT06545331 · 396 participants · Phase 1
Study of XB010 in Subjects With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia